Assyro AI

Orange Book product · Generic (ANDA)

MEZLIN

MEZLOCILLIN SODIUM MONOHYDRATE

Generic (ANDA)ANDA 062697DISCN BAYER PHARMS

At a glance

Jan 22, 1987

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 22, 1987

    40 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

MEZLOCILLIN SODIUM MONOHYDRATE

Strength

EQ 3GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 062697

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MEZLOCILLIN SODIUM MONOHYDRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.